ANGIOTECH PHARMACEUTICALS INC Selling, General and Administrative Expense
ANGIOTECH PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $70.98 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-12-31 was $19.55M.
- ANGIOTECH PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-09-30 was $16.01M, a 29.20% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-06-30 was $17.78M.
- ANGIOTECH PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-03-31 was $17.65M.
- ANGIOTECH PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $70.98M.
| Period end | Selling, General and Administrative Expense 2 month | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 5 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 8 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $19.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $35.55M derived: sum of 2 quarters · filed 2013-03-28 | $53.34M derived: sum of 3 quarters · filed 2013-03-28 | $70.98M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $16.01M 10-Q · filed 2012-11-14 | $33.79M derived: sum of 2 quarters · filed 2012-11-14 | $51.44M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $17.78M 10-Q/A · filed 2012-09-13 | $35.43M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $17.65M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $60.42M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $22.61M 10-Q · filed 2012-11-14 | $35.39M 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $12.78M 10-Q/A · filed 2012-09-13 |